|Author(s):||M. Philips*1, S. Lynch1, R. Leray1, S. Rens1, E. Maclean2|
|Affiliation(s):||1Analysis and Advocacy Unit, Medecins sans frontieres, BRUSSELS, Belgium, 2Advocacy liason officer, Medecins sans frontieres, New York, United States|
|Keywords:||HIV/AIDS, donor policies, economic crisis, scale up, treatment continuity|
The significant increase in funding for HIV/AIDS prevention, treatment and care of the last years has contributed to effectuive scale up of treatment efforts for HIv infected people and in particular those in urgent need of ARV. Recently public opinion has tried to shed doubts over the necessity to continue funding for HIV/AIDS and suggest the funding should shift to other health problems and in particular health systems support. Both at international and at country level this has been followed by significant reduction of funding for HIv treatment and in particular continued supply of essential commodities. This has come at a time where the effects ogf the financial and economic crisis start to hit developing countries.
An analysis was made of the current and intended funding streams and volumes for HIV treatment in several countries: South Africa, Lesotho, Mozambique, Malawi, Kenya, Zimbabwe and DRC. Additionally interviews of key informants among health authorities and the major funding agencies were held.
The first consequences of the funding withdrawal are being reported from various countries: capping or halting enrollment of new patients on ARV seems the earliest measure taken. Further scale up is put into question and ambitions at country level are dampened in terms of objectives set and timeline to achieve them.